EE531 Evaluation of the Cost-Effectiveness of a Nationwide Precision Medicine Program for Patients With Advanced Non-Small Cell Lung Cancer in Germany
Abstract
Authors
K Moon A Kron A Kästner G Schillinger W Hoffmann J Wolf N van den Berg